New link identified between inflammation and depression in type-1 diabetes

June 6, 2018, Society for Endocrinology

Depression in type-1 diabetes patients is associated with higher levels of the inflammatory protein galectin-3, according to research published in Endocrine Connections. These findings suggest that galectin-3 levels may be useful for diagnosis of depression or may be a new target for treating depression associated with type-1 diabetes, which could lead to better patient care.

It is well established that people with both type-1 and type-2 have an increased risk of developing depression, a debilitating mental health disorder with potentially serious consequences, but the causes remain poorly understood. Galectin-3 is a key protein involved in promoting inflammatory immune system responses that are needed to repair tissue damage throughout the body, in response to injury or disease. However, elevated levels of galectin-3 have also been linked to an increased risk of inflammatory disorders including Alzheimer's disease and cardiovascular disease. Previous research has suggested that both depression and diabetes may be associated with increased levels of inflammation in the body but the role of galectin-3 has not been investigated in either condition.

In this study, Dr. Eva Olga Melin and colleagues at Lund University in Sweden measured the galectin-3 levels of 283 men and women, aged 18-59, with type-1 diabetes, for at least one year. Incidence of depression in these patients was self-reported and assessed using the Hospital Anxiety and Depression Scale-Depression subscale and possible confounding influences of lifestyle factors including heart disease, smoking or poorly managed diabetes were accounted for in the analysis. The researchers found that both men and women with type-1 diabetes and depression also had significantly higher galectin-3 levels.

Dr. Melin comments, "We found that people with type-1 diabetes and depression had higher galectin-3 levels, yet no other diabetes-related metabolic changes could account for these elevated levels."

The team now plan to further investigate the link between type-1 diabetes, depression and galectin-3, as although these findings indicate that galectin-3 levels are associated with diabetes and depression, they are not sufficient to show any causative relationship. Larger, long-term studies are needed, as well as further analyses investigating how galectin-3 levels are linked to the increased risk of depression, what inflammatory processes are altered, and whether they can be targeted to treat .

Dr. Melin says, "Depression is a common disorder with very serious and debilitating consequences, so these findings suggest that further investigating the role of galectin-3 could lead to improved diagnosis and maybe better treatment outcomes for patients in the future."

Explore further: Mortality risk in T2DM increased with depression and/or anxiety

More information: Eva O Melin et al, Depression in type 1 diabetes was associated with high levels of circulating galectin-3, Endocrine Connections (2018). DOI: 10.1530/EC-18-0108

Related Stories

Mortality risk in T2DM increased with depression and/or anxiety

January 16, 2017
(HealthDay)—For individuals with type 2 diabetes, anxiety symptoms affect mortality risk, independently of depression symptoms, and attenuate the excess mortality associated with depression, according to a study published ...

Level of inflammation could help predict effectiveness of electroconvulsive therapy for major depression

March 6, 2018
People with major depression that has not been well controlled by medications and who have a biomarker in their blood indicating a higher level of inflammation may benefit more than people with less inflammation from electroconvulsive ...

Depression linked to CKD in patients with diabetes

July 13, 2016
(HealthDay)—For patients with diabetes, the presence of depression is associated with increased risk of developing chronic kidney disease (CKD), according to a study published online June 16 in Diabetes Care.

New findings on 'key players' in brain inflammation

March 6, 2015
Inflammation is the immune system's natural reaction to an 'aggressor' in the body or an injury, but if the inflammatory response is too strong it becomes harmful. For example, inflammation in the brain occurs when a person ...

Study assesses bidirectional link for diabetes, depression

November 19, 2012
(HealthDay)—There is a bidirectional relationship between type 2 diabetes and depression, with a stronger correlation for depression predicting diabetes onset, according to research published online Nov. 12 in Diabetes ...

Cancer detection with sugar molecules

August 14, 2017
Galectins are a family of proteins that have become a promising source of cancer research in recent years. A representative thereof is galectin-1. It sits on the surface of all human cells; on tumor cells, however, it occurs ...

Recommended for you

Kidney cells engineered to produce insulin when caffeine is present in the body

June 22, 2018
A team of researchers from ETH Zurich and the University of Basel in Switzerland and Institut Universitaire de Technologie in France has that found that embryonic kidney cells engineered to produce insulin when exposed to ...

Diagnosing diabetes from a single blood sample

June 18, 2018
Diagnosing type 2 diabetes in clinical practice may require only a single blood sample, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

Lentils significantly reduce blood glucose levels, study reveals

June 13, 2018
Replacing potatoes or rice with pulses can lower your blood glucose levels by more than 20 per cent, according to a first-ever University of Guelph study.

Is there a link between diabetes and Parkinson's disease?

June 13, 2018
People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study published in the June 13, 2018, online issue of Neurology, the medical journal ...

Double-checking diabetes medications may reduce re-hospitalizations

June 11, 2018
Clinicians may take upwards of 15 minutes to double-check a patient's medication list in an electronic health record system, but according to a new study, this reconciliation process may be well worth the time for diabetes ...

How a gene linked to obesity could provide new insights into diabetes

June 8, 2018
A gene previously linked with obesity has been found to affect how the body processes insulin, with potential implications for some forms of diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.